The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
We performed a multicenter survey using a semistructured interview in 1,072 consecutive patients with Parkinson's disease (PD) enrolled during 12 months in 55 Italian centers to assess the prevalence of nonmotor symptoms (NMSs), their association with cognitive impairment, and the impact on pat...
Saved in:
Published in | Movement disorders Vol. 24; no. 11; pp. 1641 - 1649 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
15.08.2009
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We performed a multicenter survey using a semistructured interview in 1,072 consecutive patients with Parkinson's disease (PD) enrolled during 12 months in 55 Italian centers to assess the prevalence of nonmotor symptoms (NMSs), their association with cognitive impairment, and the impact on patients' quality of life (QoL). We found that 98.6% of patients with PD reported the presence of NMSs. The most common were as follows: fatigue (58%), anxiety (56%), leg pain (38%), insomnia (37%), urgency and nocturia (35%), drooling of saliva and difficulties in maintaining concentration (31%). The mean number of NMS per patient was 7.8 (range, 0–32). NMS in the psychiatric domain were the most frequent (67%). Frequency of NMS increased along with the disease duration and severity. Patients with cognitive impairment reported more frequently apathy, attention/memory deficit, and psychiatric symptoms. Apathy was the symptom associated with worse PDQ‐39 score but also presence of fatigue, attention/memory, and psychiatric symptoms had a negative impact on QoL. These findings further support a key role for NMS in the clinical frame of PD and the need to address them specifically in clinical trials using dedicated scales. © 2009 Movement Disorder Society |
---|---|
Bibliography: | Members of the "PRIAMO Study Group" are listed as an Appendix. Potential conflict of interest: Angelo Antonini, Paolo Barone, Carlo Colosimo, Roberto Marconi, and Letterio Morgante have received consultancy fees from Boehringer-Ingelheim, Italy. istex:C2707E76FBB6EAF18B68003488BBC42442387A40 ark:/67375/WNG-MRZPBBNX-V ArticleID:MDS22643 Members of the “PRIAMO Study Group” are listed as an Potential conflict of interest: Angelo Antonini, Paolo Barone, Carlo Colosimo, Roberto Marconi, and Letterio Morgante have received consultancy fees from Boehringer‐Ingelheim, Italy. Appendix . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.22643 |